ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173046; 2) Community: the network communities that were significantly associated with the response to NSC 173046; 3) Molecule: the relationships between components within communities and NSC 173046; 4) MDR: the compounds that were significantly associated with the NSC 173046.

NSC Compound Enrichment Correlation
NSC 676343 Null 0.00322389497932883 0.011821985
NSC 682298 Camptothecin Derivative 0.00322389497932883 -0.015086477
NSC 736201 Indenoisoquinoline derivative 0.00322389497932883 0.11658668
NSC 740645 Indenoisoquinoline derivative 0.00322389497932883 0.0054360886
NSC 9706 Triethylenemelamine 0.00322389497932883 -0.058210486
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.00322389497932885 -0.25181696
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.00349006332443474 -0.094006195
NSC 36525 8-[(4-tert-butylphenoxy)methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione 0.00349006332443474 0.0068618972
NSC 50648 Null 0.00349006332443474 0.048364825
NSC 631582 Null 0.00349006332443474 -0.031666619
Total:91  Current:8    [First] [Prev] [Next] [Last]